News | Artificial Intelligence | August 24, 2020

Imaging Biometrics Announces Commercial Distribution Partnership with Arterys

The above image shows a quantitative rCBV map, automatically generated within the Arterys platform

The above image shows a quantitative rCBV map, automatically generated within the Arterys platform.

August 24, 2020 — Imaging Biometrics, LLC, a subsidiary of IQ-AI Limited and a recognized leader in quantitative imaging analysis for brain tumor diagnosis and treatment, announced it has taken its suite of products online via Arterys’s industry-leading medical AI platform. The products include IB Neuro, the premier magnetic resonance (MR) imaging dynamic susceptibility contrast (DSC) perfusion solution; IB DCE; IB’s Delta T1 mapping algorithm; and IB Diffusion. This non-exclusive agreement allows Arterys’s global customer base to access IB’s solutions for trial and purchase on the Arterys Marketplace. The above image shows a quantitative rCBV map, automatically generated within the Arterys platform According to Arterys CEO John Axerio-Cilies: “ Imaging Biometrics sets a high bar for other medical AI innovators. We’re excited to bring their algorithms online to the Arterys Marketplace and deliver the tremendous clinical value they create to oncologists and cancer patients across North America and Europe.” “We are delighted to make our products available to the doctors at hospitals around the world who are already connected to the Arterys platform and look forward to providing sophisticated imaging solutions to benefit clinicians and their patients,” said Michael Schmainda, CEO of IB. “The automated and proven accuracy of our solutions are immediately available for trial or purchase through the Arterys platform, and we look forward to expanding the use of our solutions to a much larger customer base,” Schmainda added.

Foe more information: www.imagingbiometrics.com

Related Content

Acquisition complements Hyland’s platform and rich product portfolio of automation and integration tools

Getty Images

News | Radiology Business | August 21, 2020
August 21, 2020 — Hyland, a leading content services provider, a
Change Healthcare announced the acquisition of Nucleus.io, a leader in the development of advanced, fully enabled, cloud-native imaging and workflow technology.
News | Enterprise Imaging | August 21, 2020
August 21, 2020 — Change Healthcare announced the acqui
According to ARRS' American Journal of Roentgenology (AJR), electronic consultation not only offered primary care providers (PCPs) easy access to expert opinions by radiologists, it promoted collaboration between physicians that improved patient care, including avoiding unnecessary imaging tests.

Getty Images

News | Teleradiology | August 20, 2020
August 20, 2020 — According to ARRS' 
AI-Rad Companion Prostate MR for Biopsy Support segments prostate for targeted biopsy under MRI and ultrasound fusion imaging

Image courtesy of Clinica Universidad de Navarra, Spain

News | Artificial Intelligence | August 19, 2020
August 19, 2020 — The Food and Drug Administration (FDA) has cleared two additional...
Sheer stresses on the walls of arteries are believed to cause the formation atherosclerotic plaques. This is an area of research that is expected to see increased use in the next few years. This study was presented at SCCT 2020 as an example of how sheer stresses can help evaluate and predict the patency of coronary artery bypass grafts (CABG).

Sheer stresses on the walls of arteries are believed to cause the formation atherosclerotic plaques. This is an area of research that is expected to see increased use in the next few years. This study was presented at SCCT 2020 as an example of how sheer stresses can help evaluate and predict the patency of coronary artery bypass grafts (CABG).

Feature | Computed Tomography (CT) | August 14, 2020
The latest technical advances and trends in...
Videos | Ultrasound Imaging | August 13, 2020
This is a tutorial video on how to perform an ...
As healthcare providers and essential personnel work on the front lines of the COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) wants clinicians to know that it is here to help through this critical time. Below is a preview of the latest recorded remarks given by FDA Commissioner, Stephen Hahn, M.D.
News | Coronavirus (COVID-19) | August 12, 2020
August 12, 2020 — As healthcare providers and essential personnel work on the front lines of the COVID-19 pandemic, t